Ken Nakata

A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritis

Masanao Kyuuma, K. Ebina, M. Hirao, 2022, Scientific Reports.

Comparative effectiveness of early initiation of oral nonsteroidal anti-inflammatory drug and oral acetaminophen therapies on the time to knee replacement in patients with knee osteoarthritis in Japan

K. Ohwaki, Yusuke Karasawa, Ken Nakata, 2023, BMC Musculoskeletal Disorders.

Acute effects of whole body vibration exercise on post-load glucose metabolism in healthy men: a pilot randomized crossover trial

I. Shimomura, T. Kanamoto, M. Takahara, 2021, Endocrine.

Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study

M. Hashimoto, W. Yamamoto, K. Ebina, 2023, RMD Open.

Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal-regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice.

T. Noguchi, K. Ebina, M. Hirao, 2024, Bone.

Anti–NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice

K. Ebina, M. Hirao, Y. Etani, 2023, JCI insight.